Fluorouracil is an antineoplastic anti-metabolite used in treatment protocols for many cancers, including topically for skin cancer.
EML status history
First added in 1977 (TRS 615) for Unspecified malignant neoplasms of ill-defined or unspecified sites
Removed in 2015 (TRS 994) for Unspecified malignant neoplasms of ill-defined or unspecified sites
- Parenteral > General injections > IV: 50 mg per mL in 5 mL ampoule
Dermatological medicines (topical) > Medicines affecting skin differentiation and proliferation
- Local > Topical > Ointment: 5%